Register for Upcoming Webinar on DEC. 8 @ 11AM
2026 China NMPA Bluebook is here:
On July 23, 2026, the National Center for ADR Monitoring (NCDR) of China released its annual report on medical device adverse event monitoring for 2025,
In August 2026, the NMPA issued four announcements suspending the import, distribution, and use of specific medical devices from Coloplast A/S (Denmark), Avinger, Inc. (USA),
Hainan Boao Pilot Zone allows overseas unapproved medical devices, IVDs, drugs, with clinical urgency status to be used in China. It does NOT require local
Here’s the latest China NMPA regulatory and clinical affairs news for medical device and IVDs pros in August 2026. These updates are presented by China
The NMPA issued two inspection results on July 27 and August 3, 2026 respectively to Japanese manufacturer HOYA Technosurgical and German manufacturer Eurocor Tech. NMPA
August 26-28, 2026 | Xiamen, China China Med Device is pleased to announce that Grace Fu Palma, Principal of China Med Device, has been invited
NMPA published 57 medical devices final guidelines on July 21, 2026. They are aimed to facilitate manufacturers with clarity in type testing, non-clinical and clinical
The NMPA released the “Draft Guideline on Clinical Evaluation for Cardiac Radiofrequency Ablation Devices” on July 2, 2026 for feedback. Feedbacks need to be submitted
NMPA released the “Draft Guideline on Clinical Evaluation of AI-Assisted Diagnostic Medical Devices” on June 17, 2026. Feedbacks need to be submitted by July 10,
The NMPA issued the “Technical Review Points for Tumor Gene Variation Detection Reagents (Trial)” on June 15, 2026. This guidance covers NGS‑based IVD reagents for
Here’s the latest China regulatory and clinical affairs news for medical device and IVDs pros. These updates are presented by China Med Device, LLC, your
The NMPA issued “Guideline on Product Classification of Brain-Computer Interface (BCI) Medical Devices” and “Guideline on Nomenclature of BCI Medical Devices” on June 30, 2026.